New platform technologies for viral and therapeutic evolution assays
Ended Definitive Contract Awarded Last action
- Contract number
- 140D6318C0006
- Awardee
-
Autonomous Therapeutics Inc. UEI JFHPX6TUYMU8
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $3,007,558
Award facts
- Opportunity
-
- DODSBIR171 Solicitation number
- Contract value 100% obligated
- $3,007,557.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Advanced Research Projects Agency Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 12 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Brooklyn, NY 11205, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,499,998 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $499,186 | |
| Supplemental Agreement for work within scope | $504,187 | |
| Other Administrative Action | $0 | |
| Original award | $504,187 |
Show all 11
About this award
This is a $3,007,557.97 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Autonomous Therapeutics Inc., a small business biotechnology company. The contract is for the development of new platform technologies for viral and therapeutic evolution assays under DARPA's Small Business Innovation Research (SBIR) Program Phase II. The contract has a firm fixed price pricing type and a period of performance through November 2022. Autonomous Therapeutics has also been awarded an Indefinite Delivery Vehicle (IDV) contract by DARPA, valued at up to $4,579,822, to develop and deliver therapeutic interfering particles against respiratory viral threats. Additionally, the company has received a $273,644 grant from the National Institute of Allergy and Infectious Diseases (NIAID) to advance its antiviral research capabilities. These contract and grant awards highlight Autonomous Therapeutics' expertise in developing innovative medical countermeasures and rapid-response platforms for addressing viral infectious diseases, particularly those of concern to the defense sector.
Quick answers
Who was awarded contract 140D6318C0006?
140D6318C0006 was awarded to Autonomous Therapeutics Inc. by Interior Business Center (Office of Policy Management and Budget) on December 28, 2017.
How much is contract 140D6318C0006 worth?
The government has obligated $3,007,558 on 140D6318C0006.
Which agency awarded contract 140D6318C0006?
Interior Business Center (Office of Policy Management and Budget) awarded 140D6318C0006, with funding from Defense Advanced Research Projects Agency (Department of Defense).
Was contract 140D6318C0006 competed?
The extent of competition for 140D6318C0006 was full and open competition after exclusion of sources. The government received 12 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award